Publications by authors named "J SATTLER"

Carbapenemase-producing (CP-Kp) isolates are a public health concern as they can cause severe hospital-acquired infections that are difficult to treat. It has recently been shown that CP-Kp can take up virulence factors from hypervirulent lineages. In this study, 109 clinical CP-Kp isolates from the University Hospital Cologne were examined for the presence of acquired virulence factors using whole-genome sequencing and phenotypic tests, and results were linked to clinical data.

View Article and Find Full Text PDF

Malaria vaccination approaches using live Plasmodium parasites are currently explored, with either attenuated mosquito-derived sporozoites or attenuated blood-stage parasites. Both approaches would profit from the availability of attenuated and avirulent parasites with a reduced blood-stage multiplication rate. Here we screened gene-deletion mutants of the rodent parasite P.

View Article and Find Full Text PDF

OXA-48-like enzymes represent the most frequently detected carbapenemases in Enterobacterales in Western Europe, North Africa and the Middle East. In contrast to other species, the presence of OXA-48-like in leads to an unusually susceptible phenotype with low MICs for carbapenems and piperacillin-tazobactam, which is easily missed in the diagnostic laboratory. So far, there is little data available on the genetic environments of the corresponding genes, -like, in In this study susceptibility phenotypes and genomic data of 13 OXA-48-like-producing were investigated (OXA-48,  = 9; OXA-181,  = 3; OXA-162,  = 1).

View Article and Find Full Text PDF

BackgroundCarbapenemase-producing Enterobacterales are a public health threat worldwide and OXA-48 is the most prevalent carbapenemase in Germany and western Europe. However, the molecular epidemiology of OXA-48 in species other than and remains poorly understood.AimTo analyse the molecular epidemiology of OXA-48 and OXA-48-like carbapenemases in species (spp.

View Article and Find Full Text PDF
Article Synopsis
  • Rapid detection of carbapenemase-producing Enterobacterales (CPE) is essential for effective treatment and infection control, but many existing tests miss rare enzyme variants.
  • A study compared the Clinical and Laboratory Standards Institute (CLSI)-recommended tests (mCIM and Carba NP) with new tests like NitroSpeed-Carba NP and variations of the carbapenem inactivation method (sCIM and mzCIM) using a collection of 205 clinical isolates.
  • Results show that sCIM and mzCIM excelled in sensitivity for detecting rare carbapenemases, making them promising alternatives for laboratory testing despite colorimetric tests being faster but less sensitive for rare variants.
View Article and Find Full Text PDF